Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

Press releases published on March 19, 2026

Mar. 19, 2026

Kevin Mackey and Christie Kramer-Codner of Epoch Concepts Named to 2026 Colorado Titan 100

Indeterminate EIN Presswire

Mar. 19, 2026

2026 Colorado Titan 100 Honorees

Indeterminate EIN Presswire

Mar. 19, 2026

Duda unveils new AI-powered Duda Academy to help pros launch better websites, faster

Indeterminate EIN Presswire

Mar. 19, 2026

BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

Indeterminate GlobeNewswire

Mar. 19, 2026

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire

Mar. 19, 2026

Aduro unterzeichnet Absichtserklärung zur Entwicklung eines kommerziellen Lizenzpakets für die Hydrochemolytic™-Technologie

Indeterminate GlobeNewswire

Mar. 19, 2026

Aduro signe un protocole d’accord en vue d’élaborer un ensemble de licences commerciales groupées pour la technologie Hydrochemolytic™

Indeterminate GlobeNewswire

Mar. 19, 2026

BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025

Indeterminate GlobeNewswire

Mar. 19, 2026

Odysight.ai Reports Full Year 2025 Financial Results and Strategic Progress Across Aerospace, Defense, and Industrial Markets

Indeterminate GlobeNewswire

Mar. 19, 2026

ARRAY Technologies Bolsters Board With Two Additional Directors

Indeterminate GlobeNewswire

Mar. 19, 2026

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results

Indeterminate GlobeNewswire

Mar. 19, 2026

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Indeterminate GlobeNewswire

Mar. 19, 2026

Cineplex Announces Bank Credit Agreement Extension

Indeterminate GlobeNewswire

Mar. 19, 2026

Kaida BioPharma Announces Executive Leadership Team to Advance KAD-101, Built for the Ovarian Cancer Gap

Indeterminate GlobeNewswire

Mar. 19, 2026

Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026

Indeterminate GlobeNewswire

Mar. 19, 2026

Teva Releases Q1 2026 Aide Memoire

Indeterminate GlobeNewswire

Mar. 19, 2026

Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock

Indeterminate GlobeNewswire

Mar. 19, 2026

Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

Mar. 19, 2026

Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Mar. 19, 2026

Curia erweitert seine Produktionskapazitäten in Glasgow und verbessert seine Plattform zur Entwicklung von Zelllinien

Indeterminate GlobeNewswire